Sandbox 45673: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 31: | Line 31: | ||
'''Prostate Cancer''' | '''Prostate Cancer''' | ||
Prostate cancer is an androgen dependant adenocarcinoma. The FDA has not approved finasteride as a treatment for prostate cancer. A warning was added, 5α-reductase inhibitors concerning an increased risk of high-grade prostate cancer, as the treatment of BPH lowers PSA (prostate-specific antigen), which could mask that prostate cancer is present. | Prostate cancer is an androgen dependant adenocarcinoma. The FDA has not approved finasteride as a treatment for prostate cancer. A warning was added, 5α-reductase inhibitors concerning an increased risk of high-grade prostate cancer, as the treatment of BPH lowers PSA (prostate-specific antigen), which could mask that prostate cancer is present <ref name=""> Wilt, T.J., MacDonald, R., Hagerty, K., Schellhammer, P., Kramer, B.S. (2008). Five-alpha-reductase Inhibitors for prostate cancer prevention. Cochrane Database Syst Rev (2): CD007091. doi:10.1002/14651858.CD007091. </ref>. | ||
'''Androgenetic Alopecia (AGA)''' | '''Androgenetic Alopecia (AGA)''' | ||
